COVID-19 vaccine: WHO in talks with Russia on its second vaccine EpiVacCorona
Russia registered its second coronavirus vaccine on 14 October
Developed by Vector State Research Center of Virology and Biotechnology, the EpiVacCorona vaccine completed its early stage human trials last month
The World Health Organization (WHO) on Friday said that it had had very good dialogue with developers of a second Russian vaccine candidate against COVID-19. "We will only be able to have a position on a vaccine when we see results of the phase III clinical trials," WHO Chief Scientist Soumya Swaminathan told a news conference in Geneva.